國立虎尾科技大學 |

Nanotoxicology in Safety Assessment of Nanomaterials

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Nanotoxicology in Safety Assessment of Nanomaterials/ edited by Henriqueta Louro, Maria João Silva.
其他作者:	Silva, Maria João.
面頁冊數:	XII, 439 p. 1 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Nanophysics. -
電子資源:	https://doi.org/10.1007/978-3-030-88071-2
ISBN:	9783030880712

Nanotoxicology in Safety Assessment of Nanomaterials
Nanotoxicology in Safety Assessment of Nanomaterials[electronic resource] /edited by Henriqueta Louro, Maria João Silva. - 1st ed. 2022. - XII, 439 p. 1 illus.online resource. - Advances in Experimental Medicine and Biology,13572214-8019 ;. - Advances in Experimental Medicine and Biology,889.

Part I: Nanotechnologies: Synthesis, application and characterization of nanomaterials -- Chapter 1. Challenges in Nanomaterial Characterization – From Definition to Analysis (José Catita) -- Chapter 2.Trends in the design and evaluation of polymeric nanocarriers: the in vitro nano-bio interactions (Ana Bettencourt, Lídia Gonçalves) -- Chapter 3. LipNanoCar technology - A versatile and scalable technology for the production of lipid nanoparticles (Vera L.R. Esgueira, Clara P.A. Lopes, Ana Catarina A. dos Santos, Fátima C.R.V. Pinto, Silvia A. Sousa, Dragana P.C. de Barros, Jorge H. Leitão, Luis P. Fonseca) -- Chapter 4. Dermal delivery of lipid nanoparticles: Effects on skin and assessment of absorption and safety (Fátima Pinto, Luis P. Fonseca, Dragana P.C. de Barros) -- Chapter 5. Targeting cancer by using nanoparticles to modulate Rho GTPase signalling (Paulo Matos, Joana F. S. Pereira and Peter Jordan) -- Chapter 6. Nanocelluloses: production, characterization and market (Paulo J. T. Ferreira, Ana F. Lourenço) -- Part II: Nanotoxicology: concepts and methodologies for toxicity evaluation of the nanomaterials -- Chapter 7. Nanotoxicology assessment and safety aspects of nanocelluloses for 3D bioprinting applications (Gary Chinga-Carrasco, Jennifer Rosendahl, and Julia Catalán) -- Chapter 8. New “omics” approaches as a tool to explore mechanistic nanotoxicology (Célia Ventura, Vukosava Torres, Luís Vieira, Bruno Gomes, António Sebastião Rodrigues, José Rueff, Deborah Penque, Maria João Silva) -- Chapter 9. Epigenetic mechanisms in understanding nanomaterial-induced toxicity (Manosij Ghosh, Lode Godderis, Peter Hoet) -- Chapter 10. Cellular and molecular mechanisms of toxicity of ingested nanomaterials (Adriana Vieira, Ana Gramacho, Dora Rolo, Nádia Vital, Maria João Silva, Henriqueta Louro) -- Chapter 11. Nanomaterial-induced extra-pulmonary health effects - the importance of next generation physiologically relevant in vitro test systems for the future of nanotoxicology (Ali Kermanizadeh, Gwyndaf Roberts) -- Chapter 12. Drosophila as a suitable in vivo model in the safety assessment of nanomaterials (Eşref Demir, Fatma Turna Demir, and Ricard Marcos) -- Chapter 13. Toxicological aspects of iron oxide nanoparticles (Natalia Fernández-Bertólez,b, Carla Costa, Fátima Brandão, João Paulo Teixeira, Eduardo Pásaro, Vanessa Valdiglesias, Blanca Laffon) -- Chapter 14. Hazard assessment of benchmark metallic nanomaterials through a set of in vitro genotoxicity assays (Nádia Vital, Mariana Pinhão, Naouale El Yamani, Elise Rúden-Pran, Henriqueta Louro, Maria Dušinská, Maria João Silva) -- Part III: Towards the risk assessment and regulation of nanomaterials -- Chapter 15. Nanomaterials, a new challenge in the workplace (Ana Rita Alberto, Cristina Matos, Gabriel Carmona-Aparício, Muriel Iten) -- Chapter 16. Nanomaterials in foods and human digestion: an important layer in the assessment of potential toxic effects (Carla Martins, Paula Alvito, Ricardo Assunção) -- Chapter 17. Adverse Outcome Pathways (AOPs) development, a tool for predictive nanotoxicology (Dora Rolo, Ana Tavares, Nádia Vital, Maria João Silva and Henriqueta Louro).

Since its advent, nanotechnologies are considered key enabling technologies that take advantage of a wide array of nanomaterials (NMs) for biomedical and industrial applications generating significant societal and economic benefits. However, such innovation increases human exposure to these substances through inhalation, ingestion or dermal contact raising public health concerns. Furthermore, the NMs’ specific physicochemical properties, that confer them unique beneficial characteristics, can also elicit nano-bio interactions leading to toxicity and concerns for public health. In addition, such properties can be affected by the surrounding matrix, particularly when incorporated in complex matrices such as food products, leading to secondary features potentially more relevant than primary characteristics for determining their toxicological outcome. These nano specific issues raise the question of whether the NMs may produce adverse outcomes that are not accounted for when using conventional toxicological approaches to assess their safety. Such uncertainties about the safety of NMs for human health and the environment may hamper a faster and more widespread exploration of their potentials. In response, the NMs definition has evolved, and nanotoxicology has developed towards new and more integrative approach methods to support regulatory and policy actions. This book provides a perspective on recent developments in the synthesis, application, and characterization of NMs and the related nanotechnologies, focusing on nanotoxicology for their accurate safety assessment early in the product development stage. The use of complex in vitro models, including multicellular systems and organoids, and “omics-based” approaches, such as transcriptomics or epigenomics, have greatly contributed to an in-depth understanding of the cellular and molecular mechanisms behind some NMs toxicity. Such mechanistic knowledge is equally addressed in this book and has set the basis for a predictive nanotoxicology approach building on adverse outcome pathways. In addition, considering the knowledge provided by the above-mentioned approaches, insights into risk assessment, standardization, and regulation of NMs are also included. Incorporating adequate nanosafety assessment early in the life-cycle of NMs will allow the implementation of the safe and sustainable-by-design paradigm enabling safety to keep pace with innovation. Chapters 10 and 15 are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.

ISBN: 9783030880712

Standard No.: 10.1007/978-3-030-88071-2doiSubjects--Topical Terms:

1366414
Nanophysics.

LC Class. No.: RA1190-1270

Dewey Class. No.: 615.90072

Nanotoxicology in Safety Assessment of Nanomaterials
LDR:07251nam a22004095i 4500 001 1089958
003 DE-He213
005 20220518151112.0
007 cr nn 008mamaa
008 221228s2022 sz | s |||| 0|eng d
020 $a 9783030880712 $9 978-3-030-88071-2
024 7 $a 10.1007/978-3-030-88071-2 $2 doi
035 $a 978-3-030-88071-2
050 4 $a RA1190-1270
072 7 $a MMGT $2 bicssc
072 7 $a MED000000 $2 bisacsh
072 7 $a MKGT $2 thema
082 0 4 $a 615.90072 $2 23
245 1 0 $a Nanotoxicology in Safety Assessment of Nanomaterials $h [electronic resource] / $c edited by Henriqueta Louro, Maria João Silva.
250 $a 1st ed. 2022.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a XII, 439 p. 1 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Advances in Experimental Medicine and Biology, $x 2214-8019 ; $v 1357
505 0 $a Part I: Nanotechnologies: Synthesis, application and characterization of nanomaterials -- Chapter 1. Challenges in Nanomaterial Characterization – From Definition to Analysis (José Catita) -- Chapter 2.Trends in the design and evaluation of polymeric nanocarriers: the in vitro nano-bio interactions (Ana Bettencourt, Lídia Gonçalves) -- Chapter 3. LipNanoCar technology - A versatile and scalable technology for the production of lipid nanoparticles (Vera L.R. Esgueira, Clara P.A. Lopes, Ana Catarina A. dos Santos, Fátima C.R.V. Pinto, Silvia A. Sousa, Dragana P.C. de Barros, Jorge H. Leitão, Luis P. Fonseca) -- Chapter 4. Dermal delivery of lipid nanoparticles: Effects on skin and assessment of absorption and safety (Fátima Pinto, Luis P. Fonseca, Dragana P.C. de Barros) -- Chapter 5. Targeting cancer by using nanoparticles to modulate Rho GTPase signalling (Paulo Matos, Joana F. S. Pereira and Peter Jordan) -- Chapter 6. Nanocelluloses: production, characterization and market (Paulo J. T. Ferreira, Ana F. Lourenço) -- Part II: Nanotoxicology: concepts and methodologies for toxicity evaluation of the nanomaterials -- Chapter 7. Nanotoxicology assessment and safety aspects of nanocelluloses for 3D bioprinting applications (Gary Chinga-Carrasco, Jennifer Rosendahl, and Julia Catalán) -- Chapter 8. New “omics” approaches as a tool to explore mechanistic nanotoxicology (Célia Ventura, Vukosava Torres, Luís Vieira, Bruno Gomes, António Sebastião Rodrigues, José Rueff, Deborah Penque, Maria João Silva) -- Chapter 9. Epigenetic mechanisms in understanding nanomaterial-induced toxicity (Manosij Ghosh, Lode Godderis, Peter Hoet) -- Chapter 10. Cellular and molecular mechanisms of toxicity of ingested nanomaterials (Adriana Vieira, Ana Gramacho, Dora Rolo, Nádia Vital, Maria João Silva, Henriqueta Louro) -- Chapter 11. Nanomaterial-induced extra-pulmonary health effects - the importance of next generation physiologically relevant in vitro test systems for the future of nanotoxicology (Ali Kermanizadeh, Gwyndaf Roberts) -- Chapter 12. Drosophila as a suitable in vivo model in the safety assessment of nanomaterials (Eşref Demir, Fatma Turna Demir, and Ricard Marcos) -- Chapter 13. Toxicological aspects of iron oxide nanoparticles (Natalia Fernández-Bertólez,b, Carla Costa, Fátima Brandão, João Paulo Teixeira, Eduardo Pásaro, Vanessa Valdiglesias, Blanca Laffon) -- Chapter 14. Hazard assessment of benchmark metallic nanomaterials through a set of in vitro genotoxicity assays (Nádia Vital, Mariana Pinhão, Naouale El Yamani, Elise Rúden-Pran, Henriqueta Louro, Maria Dušinská, Maria João Silva) -- Part III: Towards the risk assessment and regulation of nanomaterials -- Chapter 15. Nanomaterials, a new challenge in the workplace (Ana Rita Alberto, Cristina Matos, Gabriel Carmona-Aparício, Muriel Iten) -- Chapter 16. Nanomaterials in foods and human digestion: an important layer in the assessment of potential toxic effects (Carla Martins, Paula Alvito, Ricardo Assunção) -- Chapter 17. Adverse Outcome Pathways (AOPs) development, a tool for predictive nanotoxicology (Dora Rolo, Ana Tavares, Nádia Vital, Maria João Silva and Henriqueta Louro).
520 $a Since its advent, nanotechnologies are considered key enabling technologies that take advantage of a wide array of nanomaterials (NMs) for biomedical and industrial applications generating significant societal and economic benefits. However, such innovation increases human exposure to these substances through inhalation, ingestion or dermal contact raising public health concerns. Furthermore, the NMs’ specific physicochemical properties, that confer them unique beneficial characteristics, can also elicit nano-bio interactions leading to toxicity and concerns for public health. In addition, such properties can be affected by the surrounding matrix, particularly when incorporated in complex matrices such as food products, leading to secondary features potentially more relevant than primary characteristics for determining their toxicological outcome. These nano specific issues raise the question of whether the NMs may produce adverse outcomes that are not accounted for when using conventional toxicological approaches to assess their safety. Such uncertainties about the safety of NMs for human health and the environment may hamper a faster and more widespread exploration of their potentials. In response, the NMs definition has evolved, and nanotoxicology has developed towards new and more integrative approach methods to support regulatory and policy actions. This book provides a perspective on recent developments in the synthesis, application, and characterization of NMs and the related nanotechnologies, focusing on nanotoxicology for their accurate safety assessment early in the product development stage. The use of complex in vitro models, including multicellular systems and organoids, and “omics-based” approaches, such as transcriptomics or epigenomics, have greatly contributed to an in-depth understanding of the cellular and molecular mechanisms behind some NMs toxicity. Such mechanistic knowledge is equally addressed in this book and has set the basis for a predictive nanotoxicology approach building on adverse outcome pathways. In addition, considering the knowledge provided by the above-mentioned approaches, insights into risk assessment, standardization, and regulation of NMs are also included. Incorporating adequate nanosafety assessment early in the life-cycle of NMs will allow the implementation of the safe and sustainable-by-design paradigm enabling safety to keep pace with innovation. Chapters 10 and 15 are available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
650 2 4 $a Nanophysics. $3 1366414
650 2 4 $a Regenerative Medicine and Tissue Engineering. $3 1366894
650 0 $a Chemistry. $3 593913
650 0 $a Tissues. $3 1397278
650 0 $a Nanoscience. $3 632473
650 0 $a Regenerative medicine. $3 782729
650 0 $a Toxicology. $3 580973
700 1 $a Silva, Maria João. $e editor. $1 https://orcid.org/0000-0002-6060-0716 $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1397277
700 1 $a Louro, Henriqueta. $e editor. $1 https://orcid.org/0000-0001-9744-7332 $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1397276
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030880705
776 0 8 $i Printed edition: $z 9783030880729
776 0 8 $i Printed edition: $z 9783030880736
830 0 $a Advances in Experimental Medicine and Biology, $x 0065-2598 ; $v 889 $3 1253792
856 4 0 $u https://doi.org/10.1007/978-3-030-88071-2
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)